MoumitaBarua Canada

Back

Dr. Moumita Barua is a Clinician Scientist and Assistant Professor in the Division of Nephrology at Toronto General Hospital and the Department of Medicine at the University of Toronto, respectively. The starting point of her research is to perform DNA sequencing in adults with glomerular and chronic kidney diseases. These genetic discoveries inform clinically relevant models to better define mechanisms. Ultimately Dr. Barua's goal is to translate research findings to clinical care for the improvement of diagnostics and outcomes in kidney disease.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 HeatherAscani Chairperson University of MichiganUnited States KatherineTuttle Chairperson University of Washington School of Medicine, Division of NephrologyUnited States MatthiasKretzler Chairperson University of MichiganUnited State Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker University of MichiganUnited States Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker University of MichiganUnited State The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany Panel Discussion Hall C1	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? Fatiu AbiolaArogundade Chairperson fatiu3@yahoo.comObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comUniversidade Federal do Rio Grande do SulBrazil OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduDuke University School of MedicineUnited States Ethical Aspects of Race-based Genetic Testing AnaIltis Speaker iltisas@wfu.eduWake Forest UniversityUnited States Contribution of ApoL1 Risk Genotype to HIVAN SaraladeviNaicker Speaker University of the Witwatersrand South Africa Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa DwomoaAdu Speaker dwoms@blueyonder.co.ukUniversity of Ghana Medical SchoolGhana Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials OgoEgbuna Speaker ogo_egbuna@vrtx.comVertex Pharmaceuticals IncUnited States Q and A Hall C2	Precise Phenotyping and Treatment HeatherReich Chairperson University of Toronto, University Health NetworkCanada SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comSanatorio Parque SAArgentina Deciphering the IGAN Cell Atlas JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany Complement-mediated Kidney Diseases in the Era of Complement Inhibitors MarinaVivarelli Speaker marina.vivarelli@opbg.netLaboratory of Nephrology, Bambino Gesù Children's HospitalItaly CART-T JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio New Targets to Reduce the Burden of Rare Kidney Diseases LauraMariani Speaker University of MichiganUnited States Q and A Hall C4
3 p.m. 4 p.m.	New Tools to Study Kidney Disease RafaelMaldonado Chairperson ramaldonado@gmail.comArgentina ReikoInagi Chairperson The University of Tokyo Graduate School of MedicineJapan Understanding Glomerular Damage: From Spatial Transcriptomics to Chip Technology LauraPerin Speaker LPerin@chla.usc.eduUnited States Spatial Metabolomics of Kidney Disease TonRabelink Speaker a.j.rabelink@lumc.nlLUMCNetherlands Constructing an Epigenetic Network for Diabetic Nephropathy Sam El-Osta Speaker sam.el-osta@baker.edu.auBaker Heart and Diabetes InstituteAustralia Q and A Hall E

Day 2 - Monday April 15, 2024

Time	Session

12:15 p.m. 1:15 p.m.	Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? MartaAdragna Chairperson marta.adragna@gmail.comArgentina MoumitaBarua Chairperson moumita.barua@uhn.caCanada Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients AlbertienVan Eerde Speaker Department of Genetics, UMC Utrecht, The NetherlandsNetherlands Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only HilaMilo Rasouly Speaker Hila.MiloRasouly@columbia.eduColumbia UniversityUnited States Hall A
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker University of MichiganUnited States Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina Updates on IgAN Management HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina Membranous GN Classification and Management PierreRonco Speaker Hôpital TenonFrance MPGN Updates SanjeevSethi Speaker Mayo ClinicUnited States Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly Q and A Hall A
12:30 p.m. 1:30 p.m.	New Insights into C3 Glomerulonephritis: Focus on Pathogenesis and Potential Therapeutic Targets AnujaJava Chairperson WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States Prof LizLightstone Chairperson Imperial College LondonUnited Kingdom Complement in Kidney Disease: Overview of the Complement Cascade in Kidney Injury Peter Zipfel Speaker Peter.Zipfel@hki-jena.deLeibniz Institute for Natural Product Research and Infection BiologyGermany C3 Glomerulopathy: New Developments and Therapeutic Targets CarlaNester Speaker carla-nester@uiowa.eduUniversity of IowaUnited States Challenges in Diagnosing C3G SallyJohnson Speaker sallyajohnson73@gmail.comNational Renal Complement Therapeutics Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust, United KingdomUnited Kingdom Q and A Hall C1	Rare and Orphan Diseases AliGharavi Chairperson ag2239@cumc.columbia.eduUnited States RobertaFenoglio Chairperson roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly VaninaVazquez Chairperson azquezvanina64@gmail.comArgentina Alport Spectrum Disorders (Genetics) MoumitaBarua Speaker moumita.barua@uhn.caCanada Genetics of Nephrotic Syndrome SimoneSanna-Cherchi Speaker ss2517@cumc.columbia.eduColumbia UniversityUnited States Lupus Nephritis Transcriptomics Across Time and Space AnaMalvar Speaker avmperrin@yahoo.com.arHospotal Fernandez, Organizacion Medica de InvestigacionArgentina Q and A Hall E

Pre-Congress - Saturday April 13, 2024

Time	Session

9 a.m. 11 a.m.	Annual Review of Nephrology Course: A Review of Key Topics in Nephrology MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina MitchellRosner Chairperson Univeristy of Virginia HealthUnited States MoumitaBarua Chairperson moumita.barua@uhn.caCanada YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States Changing Paradigms in the Care of Acute Kidney Injury MarliesOstermann Speaker King's College LondonUnited Kingdom Update on Electrolyte Disorders MitchellRosner Speaker Univeristy of Virginia HealthUnited States How to Incorporate Genetic Testing in Nephrology MoumitaBarua Speaker moumita.barua@uhn.caCanada Glomerular Diseases: Case Presentation MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina Q and A Hall C4
11:30 a.m. 1:30 p.m.	Annual Review of Nephrology Course: Treatment Updates for Kidney Diseases MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina MitchellRosner Chairperson Univeristy of Virginia HealthUnited States MoumitaBarua Chairperson moumita.barua@uhn.caCanada YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States Changing Paradigms in the Care of Chronic Kidney Disease: Slowing Progression Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico What ThiagoDe Azevedo Reis Speaker thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil Therapeutic Approaches for Polycystic Kidney Disease Roman-UlrichMueller Speaker roman-ulrich.mueller@uk-koeln.deUniversity of CologneGermany Glomerular Diseases: Case Presentation MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina Q and A Hall C4
2:15 p.m. 4:15 p.m.	Annual Review of Nephrology Course: Glomerular Diseases, Transplantation and Hypertension: What MatiasFerrari Chairperson ferrarimatias89@gmail.comSANArgentina MitchellRosner Chairperson Univeristy of Virginia HealthUnited States MoumitaBarua Chairperson moumita.barua@uhn.caCanada YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States Glomerular Diseases: Update YelenaDrexler Speaker yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States Transplantation 2023 and Beyond ShrutiTapiawala Speaker shruti16374@gmail.comGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, MumbaiIndia Hypertension and the Kidney GeorgeThomas Speaker thomasg3@ccf.orgASNUnited States Glomerular Diseases: Case Presentation MatiasFerrari Speaker ferrarimatias89@gmail.comSANArgentina Q and A Hall C4